
|Articles|October 4, 2007
Ranbaxy gets agency nod for generic Biaxin suspension
Clarithromycin oral suspension approved for Ranbaxy Pharmaceuticals
Advertisement
Clarithromycin for Oral Suspension, USP, has been approved by the FDA for Ranbaxy Pharmaceuticals in strengths of 125 mg/5 ml and 250 mg/5 ml. The agent is bioequivalent to Biaxin Granules in the same strengths from Abbott Laboratories. Clarithromycin is indicated for the treatment of mild to moderate infections causes by susceptible microorganisms.
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Cigna to Remedy Years of Unfair Business Practices with Patients and Pharmacies
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
Real-World Evidence Validates Broad Mortality Benefits for Empagliflozin Beyond Clinical Trials
4
OTC Products: Smoking Cessation
5




































